Continuing Education Credits
Healthcare professionals attending the Livelong Women's Health Summit can earn CE/CME credits by completing the required CE/CME survey.
Accredited for Healthcare Professionals
In support of improving patient care, this activity has been planned and implemented by Livelong Media and Pinnacle Conference, LLC. Pinnacle Conference, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Accredited by ACCME
Accredited by ACPE
Accredited by ANCC
Medical Professional Workshop agenda
Learning Objectives
- ‣ Apply updated menopausal hormone therapy risk-benefit evidence to individual patient cases
- ‣ Recognize sex-specific cardiovascular and cognitive risk patterns in midlife women
- ‣ Counsel patients on muscle preservation, metabolic health, and GLP-1 considerations
- ‣ Integrate ovarian aging science into preventive health discussions across the lifespan
- ‣ Screen for cognitive vulnerability in perimenopausal and postmenopausal women
- ‣ Build a replicable longevity protocol framework for women from age 40 through 80 and beyond
-
The transition from reactive to proactive care: how hormonal shifts from the reproductive years through menopause reshape metabolic rate, cardiovascular risk, and cellular aging.
Closing the diagnostic gap on two of the most under-recognized reproductive conditions, endometriosis and PCOS, renamed PMOS (polyendocrine metabolic ovarian syndrome) in a June 2026 Lancet consensus. Integrating advanced hormonal profiling and real-time metabolic monitoring to move beyond standard labs and identify sub-clinical ovarian decline earlier across the reproductive lifespan.
Moderated by Dr. Hillary Lin
Facilitated peer-to-peer discussion focused on practice implementation and lab-to-protocol workflows.
Case-based hormone therapy decision-making: who is a candidate, route and formulation selection, contraindications, and the breast and cardiovascular nuance clinicians are asked about most. Includes what the timing hypothesis does and doesn't establish about hormone therapy and cognition, plus a quick evidence-tier take on peptides and nutraceuticals — established, emerging, and not-ready-for-clinic.
Moderated by Dr. Hillary Lin
Synthesizing the day's threads — ovarian aging, hormone therapy, and musculoskeletal and metabolic risk — into a stepwise clinical protocol for women from 40 to 80+, including muscle preservation and GLP-1 considerations, with concrete criteria for when to advance care or refer.
A focused look at cardiovascular risk factors unique to women in perimenopause and beyond — atypical presentation, lipid and blood pressure shifts around the menopause transition, and how hormone therapy status should (and shouldn't) factor into risk stratification.
Rapid-fire faculty session addressing regulatory hurdles, insurance integration, and complex patient case studies.
Moderated by Dr. Hillary Lin
WHO IS LIVELONG MEDIA
Livelong Media is an independent voice in the wellness landscape, grounded in editorial integrity, founded and funded by journalist and entrepreneur Brad Inman.
We maintain a "church and state" separation between journalism and commercial interests. We don’t sell supplements, medical services, or products, or push a specific cure, plan, or treatment.
Instead, we provide the insights necessary for the public to navigate their personal health journeys.
In an era where health information is either inaccessible or a veiled sales pitch, we focus on evidence-based reporting and access to world-class experts.